causal
Biotech Companies Die From Running Out of Money
Biotech companies rarely fail because a trial fails or the FDA rejects them; they fail because they run out of money, so keeping the company well capitalized is the survival priority.
causalpending
Speaker
John CrowleyEvidence Quote
“Biotech companies only fail for one reason. It's not because a trial fails, and they get a bad letter from the FDA. Because they run out of money”
Created: 11/18/2026, 9:59:31 AM
Your notes
Loading notes...